Bala Cynwyd, Pennsylvania Clinical Trials

A listing of Bala Cynwyd, Pennsylvania clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 119 clinical trials
A Phase 2 Trial of Multiple Myeloma  

A Phase 2 Trial of Multiple Myeloma

Hospital of the University of Pennsylvania
 (4.2 away)
  • 0 views
  • 11 Nov, 2025
  • 1 location
UPENN Case Test Trial 5 (Do Not Make Any Changes)

UPENN Case Test Trial 5 (Do Not Make Any Changes)

Abramson Cancer Center; Univ of Pennsylvania; Clinical Research Unit
 (6.3 away) Contact site
  • 0 views
  • 24 Apr, 2025
  • 1 location
UPENN Case Test Trial 12 (Do Not Make Any Changes)

UPENN Case Test Trial 12 (Do Not Make Any Changes)

Abramson Cancer Center; Univ of Pennsylvania; Clinical Research Unit
 (6.3 away) Contact site
  • 0 views
  • 24 Apr, 2025
  • 1 location
Anti-GITR/Anti-PD1/Stereotactic Radiosurgery in Recurrent Glioblastoma

This is a phase II study of the combination of the GITR agonist monoclonal antibody INCAGN01876, the anti-PD1 monoclonal antibody INCMGA00012, and stereotactic radiosurgery (SRS) for recurrent Glioblastoma (GBM). The investigators hypothesize that the proposed regimen will be safe and stimulate a robust anti-tumor immune response and result in improved …

gliosarcoma
growth factor
low grade glioma
karnofsky performance status
vasectomy
Hospital of the University of Pennsylvania
 (4.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors

IMC-F106C is an immune-mobilizing T cell receptor against cancer (ImmTAC ) designed for the treatment of cancers positive for the tumor-associated antigen PRAME. This is a first-in-human trial designed to evaluate the safety and efficacy of IMC-F106C in adult patients who have the appropriate HLA-A2 tissue marker and whose cancer …

Thomas Jefferson University Hospital
 (5.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +9 other locations
Reduced Radiation Dose and IR-impact on Coronary Calcium Quantification

Evaluation of reduced radiation dose iterative reconstruction reconstructions for calcium scoring compared to full dose filtered back projection reconstructions

University of Pennsylvania
 (4.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Using Direct Brain Stimulation to Study Cognitive Electrophysiology

This project forms a multi-site research collaboration to carry out verbal and spatial memory experiments in patient volunteers to better understand the neural bases of human memory, employing direct electrical brain stimulation as a tool to study those dynamics and their relationship to memory performance.

epilepsy
electrical stimulation
brain stimulation
Thomas Jefferson University Hospital
 (5.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +5 other locations
Treatment of BK Virus Infection With CTL Cells in Immunocompromised Transplant Patients

This is a pilot study using cytotoxic T lymphocytes (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Gamma-capture system will be effective in decreasing specific viral load in patients with BK virus viremia and BK virus-associated symptoms post-allogeneic hematopoietic stem cell transplantation (HSCT), renal transplantation, and chemotherapy.

Children's Hospital of Philadelphia
 (4.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19

The purpose of this study is to test the safety and tolerability of LY3819253 when it is given by injection into a vein to participants hospitalized with COVID-19. Blood tests will be done to check how much LY3819253 is in the bloodstream and how long the body takes to eliminate …

covid-19
blood test
Temple Univ School of Med
 (4.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +10 other locations
Convalescent Plasma for the Treatment of COVID-19

This protocol provides access to investigational convalescent plasma for patients in acute care facilities infected with SARS-CoV-2 who have severe or life-threatening COVID-19, or who are judged by a healthcare provider to be at high risk of progression to severe or life-threatening disease. Following provision of informed consent, patients will …

acute respiratory syndrome (sars)
covid-19
respiratory failure
dyspnea
oximetry
Thomas Jefferson University Hospital
 (5.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location